thymoquinone has been researched along with Cancer of Kidney in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Almeida, N; Camões, SP; Castro, M; Costa, JG; Fernandes, AS; Guerreiro, Í; Jackson, C; Keser, V; Manguinhas, R; Miranda, JP; Oliveira, NG; Saraiva, N | 1 |
| Chae, IG; Chun, KS; Kim, DH; Lee, MY; Park, JM; Song, NY | 1 |
| Kou, B; Kou, Q; Li, J; Liu, W; Ma, B; Sun, B; Yang, Y; Zhang, J; Zhou, J | 1 |
| Fan, Y; Gu, S; Han, R; Huang, S; Jing, X; Lei, F; Luo, A; Wang, G; Zhang, Y; Zhao, L; Zhao, X | 1 |
| Kan, SY; Kang, H; Kim, BM; Kim, GH; Kim, JH; Lee, S; Lee, YM; Lim, JH; Oh, TI; Park, EJ | 1 |
| Chang, HR; Chang, YZ; Chen, PN; Chu, SC; Hsieh, YS; Kao, SH; Liou, YF | 1 |
6 other study(ies) available for thymoquinone and Cancer of Kidney
| Article | Year |
|---|---|
A multiple endpoint approach reveals potential in vitro anticancer properties of thymoquinone in human renal carcinoma cells.
Topics: Antineoplastic Agents; Apoptosis; Benzoquinones; Cell Cycle; Cell Line, Tumor; Drugs, Chinese Herbal; Humans; Kidney Neoplasms; Nigella sativa | 2020 |
Thymoquinone induces apoptosis of human renal carcinoma Caki-1 cells by inhibiting JAK2/STAT3 through pro-oxidant effect.
Topics: Animals; Antineoplastic Agents; Apoptosis; bcl-X Protein; Benzoquinones; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferation; Cuminum; Cyclin D1; Cyclin D2; Humans; Janus Kinase 2; Kidney Neoplasms; Male; Mice; Mice, Nude; Phytochemicals; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Seeds; Signal Transduction; STAT3 Transcription Factor; Survivin; Xenograft Model Antitumor Assays | 2020 |
Thymoquinone inhibits metastatic phenotype and epithelial‑mesenchymal transition in renal cell carcinoma by regulating the LKB1/AMPK signaling pathway.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Apoptosis; Benzoquinones; Biomarkers, Tumor; Carcinoma, Renal Cell; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Kidney Neoplasms; Phosphorylation; Protein Serine-Threonine Kinases; Tumor Cells, Cultured | 2018 |
Thymoquinone inhibits the metastasis of renal cell cancer cells by inducing autophagy via AMPK/mTOR signaling pathway.
Topics: AMP-Activated Protein Kinases; Animals; Autophagy; Benzoquinones; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Humans; Kidney Neoplasms; Mice; Neoplasm Metastasis; Signal Transduction; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays | 2018 |
Thymoquinone Selectively Kills Hypoxic Renal Cancer Cells by Suppressing HIF-1α-Mediated Glycolysis.
Topics: Antineoplastic Agents; Apoptosis; Benzoquinones; Cell Hypoxia; Cell Line, Tumor; Glycolysis; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Kidney Neoplasms | 2019 |
Thymoquinone suppresses the proliferation of renal cell carcinoma cells via reactive oxygen species-induced apoptosis and reduces cell stemness.
Topics: Animals; Apoptosis; Autophagy; Benzoquinones; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferation; Cell Survival; G1 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Humans; Kidney Neoplasms; Male; Membrane Potential, Mitochondrial; Mice; Mice, Inbred BALB C; Neoplastic Stem Cells; Reactive Oxygen Species | 2019 |